Home | Contact us | Investors  
 
 

History & Milestones

 

1998

Avesthagen was founded by Dr. Villoo Morawala-Patell

2001

Avesthagen started its business operations

2001

Avesthagen received raised $1.5 million from ICICI Venture Funds as first round of venture funding

2001

Global Trust Bank became a strategic investor by investing Rs. 2 Crore

2001

TATA Industries Ltd. has picked up 5% stake in Avesthagen

2001

Avesthagen has announced an exclusive tie-up with the US-based Genetic Id Inc, thus becoming the first Indian Company to offer globally approved testing and certification for Genetically Modified Organisms (GMO’s).

2002

Avesthagen has tied up with pharma major AstraZeneca for drug discovery program in tuberculosis (TB).

2002

Avesthagen has been rated amongst the top five life sciences companies for its business plan presented at the TiEcon, 2002 (the world's largest conference on entrepreneurship held in Silicon Valley, US) held at Westin, Santa Clara, California.

2002

Wipro ties up with Avesthagen to explore BT

2003

The one billion euro French biotechnology giant, bioMerieux, in collaboration with Avesthagen, is setting up a global research project in Bangalore to develop diagnostic solutions for Tuberculosis (TB).

2003

Avesthagen has announced the launch of new facilities in Andhra Pradesh in International Crops Research Institute for the Semi-Arid Tropics (lCRISAT) at Patancheru

2003

Avesthagen entered into a alliance with bioMerieux to develop diagnostic kit based on the Affymetrix gene chip technology.

2003

Avesthagen has tied up with Imperial College London for population genomics study. The project is expected to focus on systemic lupus erythematosus (SLE) a generalized autoimmune disease

2003

Avesthagen has tied-up with state government of Andhra Pradesh and the international Crop Research Institute for Semi Arid Tropics (ICRISAT) to provide technological support to the emerging food, water and seed-testing sectors.

2003

Avesthagen and Kerala Government signed an MoU and agreed to set up a special purpose vehicle (SPV),

2003

Avesthagen gets US patents for multiple use technology

2004

Avesthagen ties up with CIPLA Ltd.

2004

Avesthagen received Rs. 2.75 crore CSIR grant for DHA research

2004

Avesthagen has obtained exclusive market rights to Raisio’s top-selling product, Benecol, in India.

2004

Godrej Industries Ltd. picks up Stake in Avesthagen

2004

Ranbaxy Laboratories Ltd and Avesthagen have signed a long term collaborative research agreement in the area of new drug discovery research

2004

Ahmedabad based Intas Pharmaceuticals Ltd and Avesthagen have entered into a collaboration wherein Avesthagen will develop novel laboratory and pilot plant scale processes for expression of recombinant proteins for Intas.

2004

Avesthagen and Nordic Bio-sciences, a subsidiary of the Denmark-based Center for Clinical & Basic Research (CCBR), have announced a strategic joint venture Avesta Nordic Research Pvt Ltd

2005

Avesthagen ties up with US Company Sequenom

2005

Expansion of Laboratory and Office space (14,500 sq ft) into Innovator building at ITPL

2005

Acquisition of Good Earth Foods Pvt Ltd.

2005

Inception of Avesta Biotherapeutics & Research Pvt Ltd (JV with Cipla Ltd, India)

2005

Strategic alliances with Nestle Nutrition SA, Novartis AG and with TNO Quality of Life

2005

Dr. Patell received the GR8! Women Award for Science & Technology

2005

Series B – follow-on investments by bioMérieux SA, France, and Godrej Industries Ltd, India.

2005

Granting of “Pearl Millet” patent in Australia

2006

Signing of agreement for construction on new headquarters with Ascendas within ITPL campus, Bangalore.

2006

Winner of the Red Hearing Asia Award for “Disruptive Innovation”

2006

Expansion of Laboratory and Office space (4,000 sq ft) into Discoverer building at ITPL

2006

Grant from Indian Department of Biotechnology under the SBIRI scheme.

2006

R&D tie up with Group Danone

2006

Strategic Alliance with Groupe Limagrain, France and inception of Atash Seeds Pvt Ltd.

2006

Extension of Nestlé Nutrition Deal

2006

Dr. Villoo Morawala-Patell receives the BioSpectrum Entrepreneur of the Year Award 2006

2007

Avesthagen gets patent for salt tolerant rice

2007

Avesthagen IP model achieves global benchmark valuation of Euro 115 mn

2007

Avesthagen announces the closure of Series "C" round Euro 25 mn. New Investors are Fidelity, Daninvest, Limagrain and Bennett Coleman Co. Ltd.

2007

AVESTHAGEN-ONE, Avesthagen breaks ground for its new corporate headquarters and R&D center at International Technology Park, Whitefield, Bangalore

2007

Avesthagen launches THE AVESTAGENOME PROJECTTM, Undertakes path breaking project for Novel Therapies and Diagnostics

2007

The Avestagenome ProjectTM Nature, March 29, 2007

2007

Dr. Villoo Morawala-Patell received the 2006 FICCI AWARD

2007

Avesthagen and Manipal Acunova announce collaboration in drug discovery, pre-clinical, clinical research including regulatory matters

2007

Avesthagen Receives INR 225 Million Share Capital Investment from NYLIM India Fund

2007

Avesthagen-Limagrain announces co-acquisition of majority stake in two seed companies

2007

Avesthagen enters into agreement with Malaysian Biotechnology Corporation to manufacture Bio Similar products

2007

Dr. Villoo Morawala-Patell’s profile was published in Nature Biotechnology, July 2007

2007

Avesthagen Acquires US Dietary Supplement Company Renaissance Herbs, Inc. (RHI)

2007

Avesthagen receives Australian Patent “A process for generating cytoplasmic male sterile line in rice and other crops by RNA editing”

2007

Avesthagen-CIPLA Joint Venture acquires Siegfried Biologics GmbH company

2007

Avesthagen arm acquires Siegfried Biologics

2007

Dr. Villoo Morawala-Patell takes over as Chairman of Avesthagen

2008

AVESTHAGEN becomes AVESTHAGEN LIMITED

2008

Avesthagen Limited launches Avestaä brand of plant–based bioactives

2008

Parsi communities in Hyderabad, Navsari and Surat provide participative support to The AVESTAGENOME Project™.

2008

Avesthagen begins Phase III Human clinical Studies for its AVESTA BRAND OF Bioactives.doc

2008

Affymetrix Signs Agreement With Avesthagen Limited

2008

AVESTHAGEN LIMITED and DuBiotech to enter into a Joint Venture

2008

AVESTHAGEN LIMITED and LIMAGRAIN Introduce India’s First 100% Biodegradable Plastic

2008

France Government honors and awards Dr. Villoo Morawala – Patell ‘Officer of the National Order of Merit’

2008

Avesthagen launches Whole wheat crackers with TeestarTM  - a clinically validated bioactive that would help those who are prone to Type II diabetes

2008

AVESTHAGEN announces the clinical trial results of TeestarTM

2008

Avesthagen partners with ShigaMediX to develop vaccines for cervical cancer and tuberculosis

2008

ABRPL Gets RCGM’s Nod for Pre-Clinical Evaluation of Biopharmaceutical Products

2008

Avesthagen and ICMR join to promote biomedical research in India

2008

Dr. Villoo Morawala-Patell Receives the Prestigious ‘Astitva Award’ for Excellence in Science and Technology

2008

Avesthagen Limited and Mallika Sarabhai Present “And They Came to India”

2008

Avesthagen Limited’s new Strategic Scientific Advisory Board addresses its multidisciplinary product pipeline

2008

Avesthagen Limited’s Intellectual Property For Diabetes Management Valued at $470 million

2008

Avesthagen Limited’s gets “License To Heal”: To Manufacture Bioactives for Ayurvedic Drugs

2008

Dr. Villoo Morawala-Patell Awarded For Achievement in Innovation And Creation Of Value. Award Conferred By The Adolfo Ibanez University

2009

AVESTHAGEN LIMITED Appoints Two Independent Board Members

2009

His Excellency Dr Boni Yayi, President, Republic of Benin today visited the campus of AVESTHAGEN LIMITED, at ITPB, Bangalore.

2009

Outstanding Entrepreneur of the Year; Dr. Villoo Morawala-Patell, Conferred Upon By The World Zarathusthi Chamber of Commerce (WZCC) at Houston,Texas, USA

2009

Avesthagen sails into Latin American waters. Forms Avesthagen Latam SpA to tap a large emerging market for its technologies, products and services. Announces strategic alliance with Chilean biotech company - Uxmal S.A.  The venture is being actively supported by the Chilean government.

2009

Avesthagen and The Harvard Medical School (HMS) Department of Genetics sign MOU to share knowledge and services in the field of Genomics

2009

Avesthagen and VTT Technical Research Centre of Finland, sign MOU to conduct product-based research projects in the  field of Theranostics

2009

AVESTHAGEN to initiate Clinical Trials for biosimilar AVDESP™

2009

Avesthagen revives IPO plans

2009

Avesthagen forms global Joint Venture with Limagrain in ATASH Seeds Private Limited 'Novel seeds for the challenges of the changing environment'

2009

Dr. Villoo Morawala Patell received prestigious ‘Karmaveer Puraskar’ as a ‘Corporate Citizen’ for her contribution in the field of agriculture and healthcare in Nov 2009 by iCONGO (Indian Confederation of NGOs) & Karmaveer Puraskar is a National Award for Social Justice & Citizen Action

2010

Avesthagen Limited was granted Patent registration for trapezoidal packaging design of its Good Earth Foods range of Products. The sub-category 09-03 includes Boxes, Cases, Containers, (Preserve) Tins and Cans and is effective from Jan 31, 2008.

2010

Avesthagen's Strategic Scientific Advisory Board meeting was held on Feb 15, 2010

2010

Avesthagen achieves significant commercial milestone
Sends first batch of cell lines for cGMP production of Clinical grade biosimilars to Inno Biologics, Malaysia

2010

Avesthagen moves towards Clinicals of its biosimilar AVENTTM

2010 Jacques Vincent joins Avesthagen Board.
Copyright © reserved 2008 Avesthagen Ltd.